Selected article for: "case series and moderate risk"
Author: Karolyi, M.; Pawelka, E.; Omid, S.; Kelani, H.; Mader, T.; Baumgartner, S.; Laferl, H.; Traugott, M.; Seitz, T.; Zoufaly, A.; Wenisch, C.
Title: Late onset pulmonary embolism in young male otherwise healthy COVID-19 patients
  • Cord-id: f1tzt6jb
  • Document date: 2020_9_23
    • ID: f1tzt6jb
    Snippet: SARS-CoV-2 infection is associated with increased risk of thrombosis in severely ill patients but little is known about the risk in outpatients with mild to moderate disease. Our case series consists of four male otherwise healthy patients between 32 and 50 years of age. Initial symptoms completely resolved but they developed new onset of dyspnea and thoracic pain at days 14 to 26. CT scan revealed pulmonary embolism in all patients which led to hospitalization. Standard anticoagulation practice
    Document: SARS-CoV-2 infection is associated with increased risk of thrombosis in severely ill patients but little is known about the risk in outpatients with mild to moderate disease. Our case series consists of four male otherwise healthy patients between 32 and 50 years of age. Initial symptoms completely resolved but they developed new onset of dyspnea and thoracic pain at days 14 to 26. CT scan revealed pulmonary embolism in all patients which led to hospitalization. Standard anticoagulation practice needs to be re-evaluated and may be considered for certain outpatients with COVID-19.

    Search related documents:
    Co phrase search for related documents
    • additional cause and low weight molecular: 1
    • admission lead and low weight: 1
    • admission lead and lymphocyte count: 1
    • low weight and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • low weight and lwmh low weight: 1
    • low weight and lwmh low weight molecular heparin: 1
    • low weight and lymphocyte count: 1, 2, 3, 4, 5
    • low weight molecular and lung injury: 1, 2, 3, 4, 5, 6
    • low weight molecular and lwmh low weight: 1
    • low weight molecular and lwmh low weight molecular heparin: 1
    • low weight molecular and lymphocyte count: 1, 2, 3, 4, 5
    • low weight molecular heparin and lung injury: 1, 2, 3
    • low weight molecular heparin and lwmh low weight: 1
    • low weight molecular heparin and lwmh low weight molecular heparin: 1
    • low weight molecular heparin and lymphocyte count: 1, 2, 3, 4
    • lung injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • lung injury severity and lymphocyte count: 1, 2, 3